Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies

J Karlsson, KM Luly, SY Tzeng, JJ Green - Advanced drug delivery reviews, 2021 - Elsevier
Glioblastoma (GBM) is an aggressive central nervous system cancer with a dismal
prognosis. The standard of care involves surgical resection followed by radiotherapy and …
被引用次数：40 相关文章

Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies

J Karlsson, KM Luly, SY Tzeng… - … Drug Delivery Reviews, 2021 - pure.johnshopkins.edu
Glioblastoma (GBM) is an aggressive central nervous system cancer with a dismal
prognosis. The standard of care involves surgical resection followed by radiotherapy and …

Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies.

J Karlsson, KM Luly, SY Tzeng… - Advanced Drug Delivery …, 2021 - europepmc.org
Glioblastoma (GBM) is an aggressive central nervous system cancer with a dismal
prognosis. The standard of care involves surgical resection followed by radiotherapy and …
[HTML] nih.gov

[HTML][HTML] Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies

J Karlsson, KM Luly, SY Tzeng… - Advanced drug delivery …, 2021 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is an aggressive central nervous system cancer with a dismal
prognosis. The standard of care involves surgical resection followed by radiotherapy and …

Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies

J Karlsson, KM Luly, SY Tzeng… - … drug delivery reviews, 2021 - pubmed.ncbi.nlm.nih.gov
Glioblastoma (GBM) is an aggressive central nervous system cancer with a dismal
prognosis. The standard of care involves surgical resection followed by radiotherapy and …